Internal Organizational Strategies to “Manufacture Doubt”: A PFAS Case Study
Environmental Health Perspectives · 17.11.2026
DOI: 10.1021/ehp.6c00278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Health Perspectives, online erschienen am 17.11.2026. Verfasst von Lauren Richter und 2 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
There is significant research on the tactics used by industries to “manufacture doubt” to delay or prevent the regulation of profitable markets. Much of the research focuses on public-facing, externally oriented strategies that a corporation may use to manipulate landscapes of knowledge production and action, targeting regulators, legislators, and consumers. Less is known about strategies to manufacture doubt within an organization. We examine the internal efforts one company used over decades to delay research, control employees, and prevent both the production and the disclosure of scientific evidence unfavorable to the company’s interests. We draw on first-hand data by an industry scientist and internal industry documents released in litigation and made publicly accessible online. We identify four mechanisms through which organizations prevent or obscure research.
Zitieren
APA
Richter, L., Hansen, K., & Cordner, A. (2026). Internal Organizational Strategies to “Manufacture Doubt”: A PFAS Case Study. Environmental Health Perspectives. https://doi.org/10.1021/ehp.6c00278
Vancouver
Richter L, Hansen K, Cordner A. Internal Organizational Strategies to “Manufacture Doubt”: A PFAS Case Study. Environmental Health Perspectives. 2026. doi:10.1021/ehp.6c00278
BibTeX
@article{Richter2026,
author = {Richter, Lauren and Hansen, Kris and Cordner, Alissa},
title = {Internal Organizational Strategies to “Manufacture Doubt”: A PFAS Case Study},
journal = {Environmental Health Perspectives},
year = {2026},
doi = {10.1021/ehp.6c00278}
}
EUVIMED